FGAM
ONC

Financial Gravity Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Financial Gravity Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$121 – 1822
2024
Q1 		$121 Buy
+1
New +$161 ﹤0.01% 958

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Financial Gravity Asset Management's ONC Position: Q2 2024 in Review

Financial Gravity Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2024, closing a stake of 1 share — an estimated $121 sold.

Financial Gravity Asset Management first reported a position in ONC in Q1 2024 and held it in 1 quarter. The position peaked at $121 in Q1 2024. 200 funds tracked by Wall St. Rank hold ONC as of Q2 2024.

  • Financial Gravity Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 1 BeOne Medicines Ltd share in Q2 2024, an estimated $121.
  • Financial Gravity Asset Management first reported a position in BeOne Medicines Ltd in Q1 2024 and held it in 1 quarter.
  • Financial Gravity Asset Management's BeOne Medicines Ltd position peaked at $121 in Q1 2024.
  • 200 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2024.

Based on Financial Gravity Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.